The Accreditation Council for CME is not the only organization suggesting that regulations regarding CME presenters' financial ties to pharmaceutical companies should be strengthened. The American Society of Clinical Oncology has changed its rules regarding conflict of interest and clinical trials — and the new policy, adopted in April, is far stricter and can affect speakers at ASCO meetings. ASCO's previous policy on financial conflicts of interest required that physicians disclose ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to ASCO Takes On CONFLICT OF INTEREST, you'll get exclusive access to a large archive of premium content.

Already registered? here.